EP3558381
Samsetning á manna fíbrínógeni í vökvaformi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
22.12.2017EP published:
7.4.2021EP application number:
17837979.8
EP translation filed:
25.6.2021Grant published:
15.7.2021EPO information:
European Patent Register
Max expiry date:
21.12.2037Expiry date:
21.12.2026Next due date:
31.12.2026
Title:
LIQUID HUMAN FIBRINOGEN COMPOSITION
Timeline
Today
22.12.2017EP application
7.4.2021EP Publication
25.6.2021Translation submitted
15.7.2021Registration published
21.12.2026Expires
Owner
Name:
Laboratoire Français du Fractionnement et des BiotechnologiesAddress:
Tour W - 102 Terrasse Boieldieu 19ème Étage, 92800 Puteaux, FR
Inventor
Name:
DEBRAIZE, ClémenceAddress:
91940 Les Ulis, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
1663181Date:
22.12.2016Country:
FR
Classification
Categories:
A61K 38/36, A61K 31/198, A61P 41/00, A61P 7/04, A61K 9/00, A61K 47/18, A61K 47/26
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 17.11.2021
Expires: 21.12.2022
Payer: Patice ehf.
Number: 6
Paid: 22.11.2022
Expires: 21.12.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 15.12.2023
Expires: 21.12.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 10.12.2024
Expires: 21.12.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 19.12.2025
Expires: 21.12.2026
Payer: Árnason Faktor ehf.